a Background: Current public health efforts often use molecular technologies to identify and contain communicable disease networks, but not for HIV. Here, we investigate how molecular epidemiology can be used to identify highly related HIV networks within a population and how voluntary contact tracing of sexual partners can be used to selectively target these networks.
Current public health efforts often use molecular technologies to identify and contain communicable disease networks, but not for HIV. Here, we investigate how molecular epidemiology can be used to identify highly related HIV networks within a population and how voluntary contact tracing of sexual partners can be used to selectively target these networks.
Methods:
We evaluated the use of HIV-1 pol sequences obtained from participants of a community-recruited cohort (n ¼ 268) and a primary infection research cohort (n ¼ 369) to define highly related transmission clusters and the use of contact tracing to link other individuals (n ¼ 36) within these clusters. The presence of transmitted drug resistance was interpreted from the pol sequences (Calibrated Population Resistance v3.0).
Results: Phylogenetic clustering was conservatively defined when the genetic distance between any two pol sequences was less than 1%, which identified 34 distinct transmission clusters within the combined community-recruited and primary infection research cohorts containing 160 individuals. Although sequences from the epidemiologically linked partners represented approximately 5% of the total sequences, they clustered with 60% of the sequences that clustered from the combined cohorts (odds ratio 21.7; P 0.01). Major resistance to at least one class of antiretroviral medication was found in 19% of clustering sequences.
Introduction
Molecular techniques can determine the transmission of communicable diseases, such as tuberculosis [1] , syphilis [2] , and gonorrhea [3] ; and public health agencies often use contact tracing of individuals with communicable diseases to contain or prevent outbreaks by identifying the source or potential recipients of the index cases' infection [4] .
The genetic composition of HIV within a person is determined by the high mutation and recombination rates [5] and the genetic background of the infecting virus [6] , the immunologic pressures [7, 8] and target cell availability of the host [9] , and potentially the pressures of antiretroviral therapy [10] . As a consequence of these factors, the genetic composition of HIV is relatively unique to each infected person. By exploiting the genetic relatedness of HIV among individuals who have transmitted HIV, viral sequence analysis can be used to investigate HIV transmissions in healthcare settings [11] , households [12] , adult entertainment settings [13] , and judiciary settings [11, 14, 15] . HIV sequence analysis has also been used on a population level to define highly related transmission networks [16] , associated with stage of HIV infection [17] [18] [19] , illicit substance use [20] , drug resistance [20, 21] , and sexually transmitted infections [18] . Efficiently identifying these highly related clusters could be used to discover sexual networks where HIV is being transmitted, and being able to access these networks could be very important for public health efforts to target prevention strategies.
Because the rate of new HIV transmissions has increased or remained constant for over a decade in the United States despite aggressive HIV awareness and behavioral modification campaigns [22] , new prevention methods are needed. Therefore, we evaluated how molecular epidemiology coupled with partner contact tracing can be used to identify individuals within a population that belong to highly related HIV transmission groups with the ultimate goal of being able to target prevention efforts to interrupt HIV transmission. Specifically, we evaluated the use of pol sequences generated for the detection of drug resistance between two San Diego cohorts, one recently HIVinfected research cohort and one mainly chronically HIVinfected clinical cohort, for the molecular surveillance of transmission clusters. We further evaluated the effectiveness of contact tracing of epidemiologically linked source partners of participants in the recently infected cohort to identify additional HIV-infected individuals who also cluster within the previously defined transmission networks. Using these methods, we outline how pol sequences and contact tracing can be used responsibly to identify groups of individuals with highly related virus, most likely representing social networks engaged in high-risk behaviors and forward HIV transmission that could be targeted for prevention interventions. 
Methods

Study participants
Epidemiologic linkage
Epidemiologic linkage was defined when a FCP participant supplied contact information on a sexual partner who they believed to be the likely source of their HIV infection, as described above. Contact tracing was performed by personnel trained in partner notification, and all information used for contact tracing was obtained voluntarily from the index FCP participant by the trained personnel. Participants identified as having primary HIV infection and eligible for the FCP were not denied participation in the FCP study if they chose not to supply contact information on their sexual partners. Those FCP participants who consented were offered three options for contact tracing of their partners: self-disclosure -they disclosed to their partners their recent HIV infection themselves and then referred them to FCP for evaluation, self-disclosure with assistance -they brought their partner to the FCP and disclosed their recent HIV infection diagnosis to their partner with FCP staff present, and anonymous third party notification -they supplied contact and identifying information to be used by FCP personnel for partner notification.
Phylogenetic linkage and transmission clusters
Even though contact tracing identified sets of HIVinfected partners, who were epidemiologically linked, it did not establish whether the HIV transmission took place between the two partners. To investigate whether HIV transmission likely occurred, we performed phylogenetic analysis on the HIV-1 pol sequences obtained from each partner (Monogram Biosciences, South San Francisco, California, USA). Sequences were initially compiled and edited in BioEdit and aligned using the MUltiple Sequence Comparison by Log-Expectation alignment tool [25, 26] . The alignment was then manually edited to preserve frame insertions and deletions if present. Phylogenetic trees and distance matrices were generated from pol sequences that were obtained from a matrix of synonymous nucleotide distances using the HasegawaKishino-Yang model of evolution with a 2 : 1 ratio of transversion to transitions in the HyPhy package [27] . In confirmatory phylogenetic analyses, amino acid residue sites associated with drug resistance [28] were stripped from all sequences to evaluate linkage independent of the presence of resistance-associated mutations. If HIV transmission occurred between partners, then the genetic distance between the HIV isolates, should be so close as to not be likely to have occurred from a third party [29] . The sequence length necessary to detect and establish clustering was dependent on the average divergence between sequences from unrelated infections and the genetic distance between viral isolates obtained from closely related epidemiologically linked partners (see Results section) [29] . Phylogenetic data were not disclosed to either partner or used for participant recruitment in any cohort.
Drug resistance
The presence of drug resistance was interpreted from the pol sequence for each individual using the Monogram Biosciences genotypic interpretation algorithm (GeneSeq). These results were made available to each participant's primary care provider for their clinical management. To investigate the prevalence of drug resistance among the cohorts, we interpreted the prevalence of drug resistance using the Calibrated Population Resistance algorithm and the surveillance drug resistance mutation list that was specifically developed for the epidemiologic surveillance of drugresistant HIV [28] among the sequences from each of the study cohorts.
Statistics
We examined bivariate relationships between cohorts, clustering, and drug resistance in contingency The demographics of the FCP and the epidemiologically linked partner cohorts were similar, more than 90% of the individuals were men and sexual exposures with men was the most reported HIV risk factor. The demographics of these two cohorts were also similar to the epidemiology of HIV in the County of San Diego as a whole (Table 1 ) [30] . The estimated mean duration of HIV infection among the FCP participants was 76 days at the time of enrollment and 38% of the epidemiologically linked partners were also found within the first year of their infection, whereas the rest (62%) were chronically infected when identified. Only two of the epidemiologically linked partners did not know that they were HIV positive; one was found during early HIV infection (LS EIA OD <0.3, consistent with infection <70 days [31] ) and the other was chronically infected. The mean duration of infection among individuals in the San Diego County cohort was most likely multiple years [23] .
Definition of transmission clusters
Because the high level of genetic variation of HIV isolated from different individuals can provide information on the transmission network of HIV [16] [17] [18] [19] , we used sequence data of the protease (codons 1-99) and reverse transcriptase (codons 1-305) coding regions of HIV pol from 268 San Diego County cohort participants, 369 FCP cohort participants, and 36 epidemiologically linked partners. The alignment was without insertions or deletions, and on average, pol sequences were 5.1% genetically different but with a wide range of divergence (0-11.2%). To define a distance cut-off of sequences as being in a cluster, we first calculated the distances between sequences for the epidemiologically linked transmitting partners. Twelve epidemiologically linked partner pairs demonstrated more than 5% genetic divergence between pol sequences, which is similar to the reported divergence between participants who were epidemiologically unlinked [13, 18] ; therefore, these epidemiologically linked partner pairs were defined as phylogenetically unlinked for the purposes of this study. Five of the 36 epidemiologically linked but phylogenetically unlinked partners clustered with someone else within the cohort. The other 24 epidemiologically linked partners had a genetic distance of less than 1% between pol sequences; therefore, these partner pairs were considered epidemiologically and phylogenetically linked. Given these data, transmission clusters were then conservatively defined when pol sequences from any two people were more than 99% genetically similar (i.e., <1% genetic distance between sequences). To further support the use of this very conservative cut-off, we found that within our combined cohort, the size of the largest cluster and the number of individuals within a cluster did not change appreciably until the genetic divergence between sequences was more than 1% (data not shown). On the basis of the less than 1% cut-off, 160 (30%) individuals were in clusters, which was, of course, less than the proportion of individuals reported to be in clusters as described previously (34-49%), which used an arbitrarily higher cut-off (1.5%) [18, 19] . Using our conservative cut-off, we were less likely to falsely include participants within transmission networks to which they did not belong, but also more likely to exclude participants from clusters from which they did belong. Because our goal was to most accurately identify transmission networks and to assess how voluntary contact tracing could identify other individuals who fit within these networks, we chose to continue our analyses using the less than 1% genetic distance cut-off, which was supported by our epidemiologically linked partner data, which demonstrated less than 1% HIV genetic distance between partners. Transmission clusters were defined after combining the San Diego County and First Choice Program cohorts (combined cohorts) but not with the sequences from the Epidemiologically linked (Epi-linked) partners; however, the epi-linked partners demonstrated the greatest odds of belonging within a transmission cluster that was previously defined. Through voluntary contact tracing of partners of participants of the FCP cohort, 36 epidemiologically linked partners were enrolled. The success of contact tracing of partners varied considerably by year of FCP enrollment (mean 11% of FCP participants recruited a partner each year, 95% confidence interval 6-16). Only about 67% of the epidemiologically linked partners were found to be phylogenetically linked (<1% genetic distance) to their FCP partner (n ¼ 24); however, the likelihood was extremely high (60%) that epidemiologically linked partners (whether or not they were phylogenetically linked) grouped within previously defined clusters of the combined San Diego County and FCP cohorts (Fig. 1) . Although sequences from the epidemiologically linked partners represented only about 5% of the total number of sequences, they clustered with 60% of the clustering sequences from the combined San Diego County and FCP cohort sequences (Table 2 ; odds ratio 21.7; P 0.01). When all sequences were combined from the San Diego County and FCP cohorts (Combined Cohort) and analyzed in conjunction with the sequences from the epidemiologically linked partners, there was a large increase in the number of clustering sequences for the San Diego County cohort (6-16%), but not for the FCP cohort (30-30%; P < 0.001 for differential increase in clustering), even though the epidemiologically linked partners were referred from the FCP participants. In total, clustering sequences represented 25% of the combined cohort with the largest cluster containing 12 individuals. Sequences from epidemiologically linked partners were found within 15 of these clusters, which included a total of 96 study participants.
Clustering characteristics
Prevalence of drug resistance
The prevalence of 'any' resistance-associated mutation, interpreted by the GeneSeq algorithm, within each of the study cohorts was San Diego County 30%, FCP 19%, epidemiologically linked partners 22%, and the clustering sequences of the combined cohorts 19%. Overall, the San Diego County and epidemiologically linked partner cohorts tended to have a greater prevalence of drug resistance as compared to the other study cohort (Table  3) . Because these cohorts were largely comprised of chronically infected individuals, the higher prevalence of drug resistance most likely represents the presence of individuals who had received antiretroviral therapy. Even though individuals were supposed to be antiretroviral naive to be eligible for the San Diego County Cohort, specific treatment data were not collected and eligibility was determined by individual clinical providers; therefore, we were unable to ensure that all of these individuals were antiretroviral naive. Theoretically, if some of the individuals in the San Diego County cohort had received antiretroviral therapy, then that could explain the observed decrease in clustering as compared with the FCP cohort. Although, forward HIV transmission from these individuals would have still been possible as the viral burden in these individuals was at least high enough for viral sequencing [32] . 
Discussion
These investigations confirm previous reports that pol sequences can be used to define highly related HIV transmission groups or clusters within a population, including the identification of clusters of drug resistance [13, [18] [19] [20] [21] . This study extends those observations with the demonstration of methods on how to increase the identification of individuals belonging to HIV transmission clusters. First, pol sequences that are obtained for the clinical evaluation of the presence of transmitted drug resistance can be used to identify transmission clusters among individuals with HIV infection of unknown duration in a population. Second, using sequences from individuals with known recent HIV infection greatly increases the size and number of transmission clusters identified. Third, epidemiologically linked partners of individuals with recent HIV infection have a very high likelihood of belonging to previously defined transmission clusters. Taken together, this information outlines how molecular surveillance and contact tracing can be used to define transmission clusters within a population and identify individuals who have a high likelihood to belong to these clusters. Future studies will need to be performed to determine how these individuals can then be targeted for prevention measures.
This study has several limitations including investigating only the San Diego population, which is primarily comprised of men who have sex with men (MSM); therefore, further investigation will be required to assess these methods in other populations. In fact, our study population is similar to previous studies evaluating molecular HIV epidemiology in that they too were predominantly MSM populations [16] [17] [18] 20] . This similarity may simply represent a selection bias in the populations studied or may suggest that these methods may offer an opportunity to assist prevention efforts in specific risk populations, such as MSM. Additionally, this study performed contact tracing only for those participants with known recent HIV infection on the basis of the assumption that they would be more likely to be able to access their source partner for contact tracing, although this may not be true. Contact tracing and epidemiologically linking partners may be just as or more successful for people with unknown duration of infection [33] , and other methods of finding transmission clusters, like respondent driven or snowball sampling, may be more effective than voluntary contact tracing [34] . It is also likely that voluntary contact tracing will not be popular among all public health settings or all risk groups, and its effectiveness will need to be independently evaluated by region and targeted group. Enrollment of epidemiologically linked partners was also inconsistent over the 11 years of the FCP cohort (range n ¼ 0-11 yearly); however, contact tracing and partner participation were completely voluntary. Despite the overall low success rate of finding and enrolling epidemiologically linked partners (<10%), the partners who were enrolled clustered within the majority of the highly related transmission groups (>60%), which demonstrates a potentially very effective way of identifying individuals who belong to transmission groups. Although not assessed in this study, the individuals identified as belonging to transmission clusters or perhaps even only identified epidemiologically linked partners could be targeted for prevention interventions, such as antiretroviral-based and behavioral modification strategies.
The approaches proposed in this study to identify transmission clusters must be used responsibly. To protect the health of their local populations, public health agencies have broad authority to examine medical records without patient consent, perform molecular epidemiology and compulsory contact tracing, and mandate testing and treatment for communicable diseases [4] . There is significant concern that similar public health procedures could place source partners of HIV transmission at legal jeopardy, because in nearly every jurisdiction in the United States, it is illegal to transmit or expose someone to HIV [15] . Although public health agencies have a long track record of protecting patient privacy, these legal issues must be considered in the context of HIV prevention efforts using molecular epidemiology and partner contact tracing [4] . Even though HIV represents a significant public health threat, it has historically been treated differently than other communicable diseases by public health agencies because of issues of stigma and discrimination; hence, HIV testing is often anonymous and partner notification is rarely performed. Allowing for HIV to be treated differently, public health agencies themselves may be complicit in the propagation of HIV stigma. Therefore, we propose the following public health model of designing prevention trials: increase the identification of individuals with primary HIV infection with nucleic acid testing and less-sensitive antibody testing [35] ; perform routine voluntary (versus mandatory) contact tracing of partners for individuals identified with primary HIV infection; require the entities that perform the resistance testing for patients provide the nucleotide sequences in a timely fashion; and perform molecular surveillance in real time and focus outreach and prevention programs (behavioral-based and antiretroviral-based) on individuals found within transmission clusters. These efforts would likely be more efficient if centralized. To further the usefulness and safety of these methods, we also propose decriminalization of unintended HIV transmission during consensual exposure and legal recognition that phylogenetic linkage using pol sequences does not prove beyond a reasonable doubt that transmission between partners occurred. Future research needs to explore the effectiveness of these proposed methods in public health settings with the ultimate outcome of reducing HIV transmission.
